Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome	Richter transformation	Recruiting	Phase 2	2026-06-30		NCT06186648

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
French Innovative Leukemia Organisation	17
Hoffmann-La Roche	280

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amiens-Picardie Chu	Amiens	France	1
Angers Chu	Angers	France	4
APHP - Hôpital Pitié Salpêtrière - Hématologie	Paris	France	4
APHP - Hôpital Saint-Antoine - Hématologie et thérapie cellulaire	Paris	France	1
APHP - Hôpital Saint-Louis - Hématologie adultes	Paris	France	2
BAYONNE - CH de la Côte Basque - Hématologie	Bayonne	France	3
Bordeaux Pessac	Pessac	France	5
Clermont-Ferrand - Chu Estaing	Clermont-Ferrand	France	6
Grenoble - CHUGA - Hématologie Clinique	Grenoble	France	4
LILLE CHU - Hôpital Claude Huriez	Lille	France	4
LILLE GHICL - Hôpital Saint Vincent de Paul	Lille	France	4
LIMOGES - CHU Dupuytren 1	Limoges	France	2
LYON HCL - CH Lyon Sud	Pierre-Bénite	France	3
LYON-Centre Léon Bérard	Lyon	France	4
MONTPELLIER - Hôpital Saint-Eloi - Hématologie Clinique	Montpellier	France	4
NANCY - CHU Brabois	Vandœuvre-lès-Nancy	France	3
Reims Chu	Reims	France	5
RENNES - CHU Pontchaillou - Hématologie Clinique	Rennes	France	4
ROUEN - Centre Henri Becquerel - Service Hématologie Clinique	Rouen	France	4
Strasbourg - Icans	Strasbourg	France	5
Toulouse - IUCT Oncopole - Service d'Hématologie	Toulouse	France	5
TOURS - Hôpital Bretonneau	Tours	France	5
VERSAILLES - Hôpital André Mignot	Versailles	France	6

Clinical trials